BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19003707)

  • 1. Participation in research and social context: the case of population-based cancer registration, surveillance, and research.
    McLaughlin RH
    Am J Bioeth; 2008 Oct; 8(10):41-2. PubMed ID: 19003707
    [No Abstract]   [Full Text] [Related]  

  • 2. A duty to participate in research: does social context matter?
    de Melo-Martin I
    Am J Bioeth; 2008 Oct; 8(10):28-36. PubMed ID: 19003704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correcting social ills through mandatory research participation.
    Ho A
    Am J Bioeth; 2008 Oct; 8(10):39-40. PubMed ID: 19003706
    [No Abstract]   [Full Text] [Related]  

  • 4. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to open peer commentaries on "A duty to participate in research: does social context matter?".
    de Melo-Martin I
    Am J Bioeth; 2008 Oct; 8(10):W3-4. PubMed ID: 19003693
    [No Abstract]   [Full Text] [Related]  

  • 6. More controversy over breast cancer rates in the USA.
    Brown S
    Menopause Int; 2007 Jun; 13(2):51-2. PubMed ID: 17802647
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.
    Clarke CA; Glaser SL; Uratsu CS; Selby JV; Kushi LH; Herrinton LJ
    J Clin Oncol; 2006 Nov; 24(33):e49-50. PubMed ID: 17114650
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer decline mirrors fall in hormone use, spurs both debate and research.
    McNeil C
    J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300
    [No Abstract]   [Full Text] [Related]  

  • 9. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 10. Unreported VA data may affect SEER research, cancer surveillance, and statistics gathering.
    Savage L
    J Natl Cancer Inst; 2007 Dec; 99(23):1744-5, 1752. PubMed ID: 18042924
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot test for linking population-based cancer registries with CCG/POG pediatric registries.
    Ross F
    J Ky Med Assoc; 2002 May; 100(5):195-9. PubMed ID: 12040910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research participation and internal normativity: understanding why people participate.
    Fry CL
    Am J Bioeth; 2008 Oct; 8(10):43-4. PubMed ID: 19003708
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Louwman WJ et al. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 19:97-106.
    Dören M
    Cancer Causes Control; 2008 Nov; 19(9):1001. PubMed ID: 18409010
    [No Abstract]   [Full Text] [Related]  

  • 14. Future of cancer incidence in the United States: burdens upon an aging, changing nation.
    Smith BD; Smith GL; Hurria A; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2009 Jun; 27(17):2758-65. PubMed ID: 19403886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood cancer patients' access to cooperative group cancer programs: a population-based study.
    Liu L; Krailo M; Reaman GH; Bernstein L;
    Cancer; 2003 Mar; 97(5):1339-45. PubMed ID: 12599243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data.
    Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW
    Am J Manag Care; 2004 Apr; 10(4):257-62. PubMed ID: 15124502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
    Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
    J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
    [No Abstract]   [Full Text] [Related]  

  • 18. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cancer clip.
    Redmond J
    Ky Nurse; 2003; 51(1):13. PubMed ID: 12655812
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer incidence and incidence rates in Japan in 1987: estimates based on data from nine population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan.
    Jpn J Clin Oncol; 1992 Dec; 22(6):437-42. PubMed ID: 1291762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.